LIVE SESSION BRIEF Biotechnology $24.57B Cap Quant: HOLD

BioNTech SE (BNTX) — Live Session & Technical Brief

Updated Nov 21, 2026 5:03 AM ET · Prev Close $81.38

Pro Workspace
Last Session Price
$80.96 -0.52%
-$0.42 vs $81.38 prior close
Intraday Range
$80.27 – $82.86
Open $80.82
Relative Volume
1.68x Avg
1,683,050 sh
52-Week Range
$79.52 – $124.00
Benchmark Alpha
+3.12% vs SPY
+5.15% vs QQQ
20-Session Trend -6.8%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-0.52%) in Biotechnology

BioNTech SE (Bntx) is trading within a tight intraday band at $80.96 (-0.52%, 1.68x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, BNTX is outperforming the S&P 500 by +3.12%. 14-day RSI stands at 32.1, keeping momentum in a bearish regime.

NEWS 70% Weight
BioNTech May Be the Next Moderna. Even if it Isn t, the Stock Is a Buy.

The firm has multiple catalysts that could generate a rally of 35 for the stock.

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($80.96) trades relative to 20-day SMA ($86.32) and 50-day SMA ($91.52).

Volume Confirmation
HIGH VOLUME (1.68x) Distribution
Institutional participation confirms directional price action.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

BNTX outperforming the S&P 500 by +3.12%
BNTX Session
-0.52%
$80.96
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +3.12% Alpha vs QQQ: +5.15% Alpha vs XLV: -0.40%

Recent BNTX Catalyst Headlines

Verified Wire
BioNTech BNTX Stock Looks Fully Valued As Sales Face Pressure

BioNTech has seen its share price fall sharply over the past few years, even as the business shifts away from a single Covid-19 product toward a broader oncology portfolio. With the stock now trading well below its earli

Yahoo Finance · Nov 13, 2026
BioNTech BNTX Dropped, So What Is Driving Attention Now?

BioNTech NasdaqGS BNTX is back in focus after Arbutus Biopharma and Genevant expanded their patent enforcement campaign by filing new lawsuits in Japan and updating an existing Canadian case tied to mRNA lipid nanopartic

Yahoo Finance · Nov 13, 2026

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$78.93
Short-term support band
Upper Bound
$82.99
Short-term resistance band
Key Inflection Level
$86.32 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $86.32 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (BNTX)

BEARISH MA TREND
RSI (14)
32.1
Bearish
20-Day SMA
$86.32
Below 20d
50-Day SMA
$91.52
Below 50d
MACD Signal
Bearish
MACD -2.58
ADX (14)
17.8
Weak trend
10d Momentum
-6.55
Strong downward 10-day pressure

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Reddit communities: 1 comment (Neutral)

About BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered …

Sector
Healthcare
Market Cap
$24.57B
Forward P/E
7.0x
Employees
6,772

Get Instant BNTX Catalyst Alerts

Receive an email alert when BNTX triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

BNTX Session & Catalyst FAQ

Why is BNTX stock trading near flat today?

BioNTech SE (Bntx) is trading within a tight intraday band at $80.96 (-0.52%, 1.68x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, BNTX is outperforming the S&P 500 by +3.12%. 14-day RSI stands at 32.1, keeping momentum in a bearish regime.

Is BNTX stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 1.68x relative volume (high participation). Our multi-factor model currently rates BNTX as HOLD. Review full valuation, quality, and timing signals on the BNTX Buy or Sell Decision Brief →

What is BNTX's intrinsic value and expected trading range?

At $80.96, BNTX's modeled 1-to-3 session range is $78.93 – $82.99, with a key inflection level at $86.32 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the BNTX Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for BNTX?

RSI at 32.1 reflects soft below-midline momentum. BNTX trades at $80.96 relative to its 20-day SMA ($86.32) and 50-day SMA ($91.52), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs